Results 261 to 270 of about 14,397,534 (393)

Patch Testing in Non-Immediate Drug Eruptions [PDF]

, 2008
Antonino Romano, Marinella Viola, Francesco Gaeta, G Rumi, Michela Maggioletti   +4 more
openalex   +1 more source

Identifying prognostic targets in metastatic prostate cancer beyond AR

FEBS Open Bio, EarlyView.
Genome‐wide functional screens combined with a large gene expression database and clinical outcomes can identify new therapeutic vulnerabilities in prostate cancer. Eight potentially druggable targets demonstrated strong dependency in cell lines, were associated with worse prognosis clinically, and showed evidence of protein expression in prostate ...
Emily Feng, Eric Feng, Tracy Berg, Isabella S. Nguyen, Lilac G. Nguyen, William Chen, Meng Zhang, David Quigley, Marina Sharifi, Haolong Li, Ilsa Coleman, Peter S. Nelson, Martin Sjöström, Shuang G. Zhao   +13 more
wiley   +1 more source

A simple patch test (empty tablet cover patch test) demonstrating ornidazone as offending agent in a patient of fixed drug eruption: Report of a clinical case, a new modified technique and systematic review of literature.

Indian J Pharmacol
Balamurugan R, Sarma P, Nagendran P, Nicodemus DS, Sharma S.   +4 more
europepmc   +1 more source

Patch Testing: Another Steroid‐Sparing Agent to Consider in Children [PDF]

, 2008
Sharon E. Jacob, Cynthia J. Burk, Elizabeth Alvarez Connelly   +2 more
openalex   +1 more source

Current trends in single‐cell RNA sequencing applications in diabetes mellitus

FEBS Open Bio, EarlyView.
Single‐cell RNA sequencing is a powerful approach to decipher the cellular and molecular landscape at a single‐cell resolution. The rapid development of this technology has led to a wide range of applications, including the detection of cellular and molecular mechanisms and the identification and introduction of novel potential diagnostic and ...
Seyed Sajjad Zadian, Khodakaram Jahanbin, Shekoofeh Nikooei, Marzieh Rostaminejad, Arezoo Rahimi, Pedram Abdizadeh, Behnam Alipoor   +6 more
wiley   +1 more source

Are Adverse Skin Reactions to Cosmetics Underestimated in the Clinical Assessment of Contact Dermatitis? A Prospective Study among 1075 Patients Attending Swedish Patch Test Clinics

, 2004
Magnus Lindberg, Monica Tammela, Åsa Boström, Torkel Fischer, Annica Inerot, Karin Sundberg, Berit Berne   +6 more
openalex   +1 more source

An efficient strategy for producing RNA‐free Nucleocapsid protein of SARS‐CoV‐2 for biochemical and structural investigations

FEBS Open Bio, EarlyView.
Cleavable N‐terminal Thioredoxin fusion enabled soluble expression and purification of otherwise insoluble SARS‐CoV‐2 Nucleocapsid (N) protein. A four‐step purification strategy yielded highly homogeneous, RNA‐free N protein. Binding assays showed high RNA affinity (Kd ~ 28 nm). The study will facilitate high‐resolution structural studies of N protein,
Shweta Singh, Gagan D. Gupta
wiley   +1 more source

Patch test results in paediatric patients with atopic dermatitis in Laos. [PDF]

PLoS One, 2020
Wootton CI, Sodaly MK, Billamay SX, English JSC, Mayxay M.   +4 more
europepmc   +1 more source

Atopy Patch Test – Reproducibility and Elicitation of Itch in Different Application Sites

, 2005
Stephanie Weissenbacher, Theresa Bacon, Darren Targett, Heidrun Behrendt, Johannes Ring, Ulf Darsow   +5 more
openalex   +1 more source

Preparation and characterization of renal cell peptides from fetal rats for their antitumor activity

FEBS Open Bio, EarlyView.
This study aimed to prepare renal cells (RCs) from fetal rats which were digested by enzymes. Candidate peptides RCPs were characterized by capillary HPLC and MS and their bioactivity was predicted using peptideranker. The predicted top 10 bioactive peptides were synthesized.
Zhe Zhang, Yuan Cao, Jing Du, Ying Zhang, Junxia Wang, Ying Yuan, Lianqing Sun   +6 more
wiley   +1 more source